Polyamine metabolism during sclerotial development of Sclerotinia sclerotiorum.
A study on polyamine metabolism and the consequences of polyamine biosynthesis inhibition on the development of Sclerotinia sclerotiorum sclerotia was conducted. Concentrations of the triamine spermidine and the tetramine spermine, as well as ornithine decarboxylase and S-adenosyl-methionine decarboxylase activities, decreased during sclerotia maturation. In turn, the concentration of the diamine putrescine was reduced at early stages of sclerotial development but it increased later on. This increment was not related to de novo biosynthesis, as demonstrated by the continuous decrease in ornithine decarboxylase activity. Alternatively, it could be explained by the release of putrescine from the conjugated polyamine pool. Alpha-difluoro-methylornithine and cyclohexylamine, which inhibit putrescine and spermidine biosynthesis, respectively, decreased mycelial growth, but did not reduce the number of sclerotia produced in vitro even though they disrupted polyamine metabolism during sclerotial development. It can be concluded that sclerotial development is less dependent on polyamine biosynthesis than mycelial growth, and that the increase of free putrescine is a typical feature of sclerotial development. The relationship between polyamine metabolism and sclerotial development, as well as the potential of polyamine biosynthesis inhibition as a strategy for the control of plant diseases caused by sclerotial fungi are discussed.
Gárriz
Andrés
A
Instituto de Investigaciones Biotecnológicas, Universidad Nacional de General San Martín-Consejo Nacional de Investigaciones Científicas y Técnicas, Casilla de Correo 164, (7130) Chascomús, Buenos Aires, Argentina.
Gonzalez
María E
ME
Marina
María
M
Ruiz
Oscar A
OA
Pieckenstain
Fernando L
FL
D012437:Adenosylmethionine Decarboxylase / Q000378:metabolism; D001203:Ascomycota / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development / Q000378:metabolism*; D003514:Cyclohexylamines / Q000494:pharmacology; D000518:Eflornithine / Q000494:pharmacology; D056229:Fungal Structures / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development / Q000378:metabolism; D006368:Helianthus / Q000382:microbiology; D025282:Mycelium / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D009955:Ornithine Decarboxylase / Q000378:metabolism; D010935:Plant Diseases / Q000382:microbiology; D011073:Polyamines / Q000037:antagonists & inhibitors / Q000378:metabolism*
D003514:Cyclohexylamines; D011073:Polyamines; D009955:Ornithine Decarboxylase; D012437:Adenosylmethionine Decarboxylase; D000518:Eflornithine